The pharmaceutical world is observing a remarkable shift in diabetes therapy with the arrival of GLP-1 transdermal devices. These patches offer a possibly more user-friendly alternative to injections of GLP-1 drugs, reducing the requirement of daily needle pricks. The innovation administers the m